NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas
- 31 May 2005
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 31 (4) , 386-392
- https://doi.org/10.1016/j.ejso.2004.10.010
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the LiverAnnals of Surgical Oncology, 2003
- Inhibition of interferon-γ-activated nuclear factor-κB by cyclosporin A: a possible mechanism for synergistic induction of apoptosis by interferon-γ and cyclosporin A in gastric carcinoma cellsBiochemical and Biophysical Research Communications, 2003
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003
- Nuclear transcription factor-κB as a target for cancer drug developmentLeukemia, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Adenovirus-mediated expression of a mutant IκB kinase 2 inhibits the response of endothelial cells to inflammatory stimuliBlood, 2001
- Nuclear Factor-κB Regulates Cyclooxygenase-2 Expression and Cell Proliferation in Human Gastric Cancer CellsLaboratory Investigation, 2001
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Efficient adenoviral transfer of NF-?B inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosisInternational Journal of Cancer, 1999
- Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998